Annual Working Capital
$233.64 M
+$61.13 M+35.43%
December 31, 2023
Summary
- As of February 7, 2025, ABOS annual working capital is $233.64 million, with the most recent change of +$61.13 million (+35.43%) on December 31, 2023.
- During the last 3 years, ABOS annual working capital has risen by +$195.58 million (+513.85%).
- ABOS annual working capital is now at all-time high.
Performance
ABOS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$187.72 M
-$63.83 M-25.37%
September 30, 2024
Summary
- As of February 7, 2025, ABOS quarterly working capital is $187.72 million, with the most recent change of -$63.83 million (-25.37%) on September 30, 2024.
- Over the past year, ABOS quarterly working capital has dropped by -$24.78 million (-11.66%).
- ABOS quarterly working capital is now -25.37% below its all-time high of $251.55 million, reached on June 30, 2024.
Performance
ABOS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ABOS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.4% | -11.7% |
| 3 y3 years | +513.9% | +33.1% |
| 5 y5 years | +3903.5% | +33.1% |
ABOS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.4% | -25.4% | +38.8% |
| 5 y | 5-year | at high | +3903.5% | -25.4% | +1618.9% |
| alltime | all time | at high | +3903.5% | -25.4% | +1618.9% |
Acumen Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $187.72 M(-25.4%) |
| Jun 2024 | - | $251.55 M(+1.7%) |
| Mar 2024 | - | $247.36 M(+5.9%) |
| Dec 2023 | $233.64 M(+35.4%) | $233.64 M(+10.0%) |
| Sep 2023 | - | $212.50 M(+50.7%) |
| Jun 2023 | - | $141.01 M(+4.3%) |
| Mar 2023 | - | $135.25 M(-21.6%) |
| Dec 2022 | $172.52 M | $172.52 M(-12.0%) |
| Sep 2022 | - | $195.95 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $185.92 M(-1.2%) |
| Mar 2022 | - | $188.16 M(-2.8%) |
| Dec 2021 | $193.51 M(+408.4%) | $193.51 M(-4.9%) |
| Sep 2021 | - | $203.42 M(+208.0%) |
| Jun 2021 | - | $66.05 M(+504.8%) |
| Mar 2021 | - | $10.92 M(-71.3%) |
| Dec 2020 | $38.06 M(+552.2%) | - |
| Dec 2020 | - | $38.06 M |
| Dec 2019 | $5.84 M | - |
FAQ
- What is Acumen Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual working capital year-on-year change?
- What is Acumen Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly working capital year-on-year change?
What is Acumen Pharmaceuticals annual working capital?
The current annual working capital of ABOS is $233.64 M
What is the all time high annual working capital for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual working capital is $233.64 M
What is Acumen Pharmaceuticals annual working capital year-on-year change?
Over the past year, ABOS annual working capital has changed by +$61.13 M (+35.43%)
What is Acumen Pharmaceuticals quarterly working capital?
The current quarterly working capital of ABOS is $187.72 M
What is the all time high quarterly working capital for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly working capital is $251.55 M
What is Acumen Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ABOS quarterly working capital has changed by -$24.78 M (-11.66%)